Iovance Biotherapeutics Dividend
Dividend criteria checks 0/6
Iovance Biotherapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$1.59 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results
Apr 09Iovance Biotherapeutics: Initial Amtagvi Launch In Focus
Mar 25Iovance Biotherapeutics: Amtagvi's Pioneering Approval Sets New Standards In Melanoma
Feb 20Iovance Biotherapeutics: Preparing For Volatility Around Lifileucel's Upcoming PDUFA Date
Jan 19Iovance Biotherapeutics Approaches Key Regulatory Milestone As Clinical Momentum Accelerates
Sep 27Iovance submits rolling license application to FDA for skin cancer treatment lifileucel
Aug 25Calculating The Fair Value Of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Aug 25Iovance Biotherapeutics falls 6% on Q2 2022 bottom line miss
Aug 04Iovance: TIL Cell Therapy Set To Prove Itself
Jul 11Iovance: Onward To Approval
Apr 20Iovance Biotherapeutics: An Unproven Biopharmaceutical Company With Significant Upside
Mar 25Iovance Biotherapeutics: Uncertainty And Opportunity
Dec 05Iovanve Biotherapeutics (IOVA) Presents At 2021 ASCO Annual Virtual Meeting - Slideshow
Jun 16Iovance Bio reports 33-month follow up data for lifileucel in advanced melanoma at ASCO21
Jun 07Iovance: Down And Rebound
May 30Here's Why We're Not Too Worried About Iovance Biotherapeutics' (NASDAQ:IOVA) Cash Burn Situation
Mar 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if IOVA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IOVA's dividend payments have been increasing.
Dividend Yield vs Market
Iovance Biotherapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (IOVA) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (IOVA) | n/a |
Notable Dividend: Unable to evaluate IOVA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IOVA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate IOVA's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as IOVA has not reported any payouts.